Hodgkin lymphoma

non-Hodgkins lymphoma: Distinct from Hodgkin lymphoma both morphologically and biologically, non-Hodgkin lymphoma (NHL) is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss. The clinical course varies according to the morphologic type. NHL is clinically classified as indolent, aggressive, or having a variable clinical course. NHL can be of B-or T-/NK-cell lineage.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries Inpat., Oupat., Death

Hospital Discharge: ICD-10 C81
Hospital discharge: ICD-9 201
Cause of death: ICD-10 C81
Cause of death: ICD-9 201

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector CD2_HODGKIN_LYMPHOMA

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF4
Parent code in ICD-10 C81-C96
Name in latin Morbus Hodgkin

Summary Statistics

Key figures

All Female Male
Number of individuals 454 227 227
Unadjusted prevalence (%) 0.17 0.15 0.20
Mean age at first event (years) 46.84 41.33 52.35


Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.10 7.34 [3.74, 14.39] 6.4e-9 75
15 years 0.05 7.90 [4.00, 15.59] 2.6e-9 68
5 years 0.02 15.04 [8.56, 26.40] 3.9e-21 38
1 year - - - -


Index endpoint: CD2_HODGKIN_LYMPHOMA – Hodgkin lymphoma
GWS hits: 0

Survival analyses between endpoints


before Hodgkin lymphoma
after Hodgkin lymphoma

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Hodgkin lymphoma